Understanding CDSCO’s Dossier-Based Submission Framework
The Central Drugs Standard Control Organization (CDSCO) plays a crucial role in regulating drugs and medical devices in India. To improve consistency and efficiency in regulatory approvals, CDSCO has introduced a structured dossier-based submission system. This approach ensures that applications are comprehensive, standardized, and easier for regulators to evaluate.
Key Compliances under Narcotic Drugs and Psychotropic Substances Act, 1985 (Part 2)
The Narcotic Drugs and Psychotropic Substances Act, 1985 was enacted to consolidate and amend laws relating to narcotic drugs and psychotropic substances, providing strict measures for their control, regulation, and prevention of illegal activities, including forfeiture of property linked to illicit trafficking, while also implementing international conventions. The Narcotic Drugs and Psychotropic Substances Rules, 1985 were introduced under the Act to regulate operations involving these substances, ensuring their use is limited to medical and scientific purposes and preventing misuse and illegal trade.
Key Compliances under Narcotic Drugs and Psychotropic Substances Act, 1985 (Part 1)
The Narcotic Drugs and Psychotropic Substances Act, 1985 was enacted to consolidate and amend laws relating to narcotic drugs and psychotropic substances, providing strict measures for their control, regulation, and prevention of illegal activities, including forfeiture of property linked to illicit trafficking, while also implementing international conventions. The Narcotic Drugs and Psychotropic Substances Rules, 1985 were introduced under the Act to regulate operations involving these substances, ensuring their use is limited to medical and scientific purposes and preventing misuse and illegal trade.
Key Compliances under Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Order, 2013
The Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Order, 2013 was issued under the NDPS Act to regulate and monitor controlled substances used in the manufacture of narcotic drugs and psychotropic substances. It aims to prevent diversion of such substances for illicit use while ensuring their availability for legitimate industrial, medical, and scientific purposes.
Compliances under Drugs Rules, 1945 [Part VIII, IX]
![Compliances under Drugs Rules, 1945 [Part VIII, IX]](https://1-comply.com/wp-content/uploads/2026/01/ChatGPT-Image-Jan-21-2026-05_16_08-PM-1024x683.png)
The Drugs Rules, 1945 were introduced under the Drugs and Cosmetics Act to standardize how medicines are manufactured, tested, and sold across India. They emerged during a period when the government sought stronger safeguards against unsafe or ineffective pharmaceuticals. The rules laid out scientific criteria for quality, labeling, storage, and distribution of medicinal products. By bringing regulatory clarity, they helped protect public health and support the growth of a structured pharmaceutical sector.
Compliances under Drugs Rules, 1945 [part VI, VII, VIII A ]
![Compliances under Drugs Rules, 1945 [Part VI, VII, VIII A]](https://1-comply.com/wp-content/uploads/2026/01/ChatGPT-Image-Jan-21-2026-03_55_10-PM-1024x683.png)
The Drugs Rules, 1945 were introduced under the Drugs and Cosmetics Act to standardize how medicines are manufactured, tested, and sold across India. They emerged during a period when the government sought stronger safeguards against unsafe or ineffective pharmaceuticals. The rules laid out scientific criteria for quality, labeling, storage, and distribution of medicinal products.
Compliances under Drugs Rules, 1945 [Part IV ]
![Compliances under Drugs Rules, 1945 [Part IV]](https://1-comply.com/wp-content/uploads/2026/01/ChatGPT-Image-Jan-21-2026-03_40_50-PM-1024x683.png)
The Drugs Rules, 1945 were introduced under the Drugs and Cosmetics Act to standardize how medicines are manufactured, tested, and sold across India. They emerged during a period when the government sought stronger safeguards against unsafe or ineffective pharmaceuticals. The rules laid out scientific criteria for quality, labeling, storage, and distribution of medicinal products. By bringing regulatory clarity, they helped protect public health and support the growth of a structured pharmaceutical sector.
Key Compliances under New Drugs and Clinical Trials Rules, 2019 [Chapter VIII, IX, X, XI ]
![Key Compliances under New Drugs and Clinical Trials Rules, 2019 [Chapter VIII, IX, X, XI]](https://1-comply.com/wp-content/uploads/2026/01/ChatGPT-Image-Jan-21-2026-03_12_00-PM-1024x683.png)
The New Drugs and Clinical Trials Rules, 2019 were notified by the Government of India on 19 March 2019 to replace parts of the earlier Drugs and Cosmetics Rules of 1945 and create a modern, transparent framework for regulating new drugs, investigational new drugs, clinical trials, bioavailability/bioequivalence studies, and ethics committees under the Drugs and Cosmetics Act, 1940
Key Compliances under New Drugs and Clinical Trials Rules, 2019 [Chapter V(Part B ), VI & VII ]
![Key Compliances under New Drugs and Clinical Trials Rules, 2019 [Chapter V (Part B), VI & VII]](https://1-comply.com/wp-content/uploads/2026/01/ChatGPT-Image-Jan-21-2026-02_53_10-PM-1024x683.png)
The New Drugs and Clinical Trials Rules, 2019 were notified by the Government of India on 19 March 2019 to replace parts of the earlier Drugs and Cosmetics Rules of 1945 and create a modern, transparent framework for regulating new drugs, investigational new drugs, clinical trials, bioavailability/bioequivalence studies, and ethics committees under the Drugs and Cosmetics Act, 1940.
Key Compliances under New Drugs and Clinical Trials Rules, 2019 [Chapter III, IV & V (Part A )]
![Key Compliances under New Drugs and Clinical Trials Rules, 2019 [Chapter III, IV & V (Part A)]](https://1-comply.com/wp-content/uploads/2026/01/ChatGPT-Image-Jan-20-2026-05_33_33-PM-1024x683.png)
The New Drugs and Clinical Trials Rules, 2019 were notified by the Government of India on 19 March 2019 to replace parts of the earlier Drugs and Cosmetics Rules of 1945 and create a modern, transparent framework for regulating new drugs, investigational new drugs, clinical trials, bioavailability/bioequivalence studies, and ethics committees under the Drugs and Cosmetics Act, 1940.